{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:41:20Z","timestamp":1783496480358,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3932,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ymthe.2005.09.003","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:43:41Z","timestamp":1131025421000},"page":"67-76","source":"Crossref","is-referenced-by-count":120,"title":["High Levels of Persistent Expression of \u03b11-Antitrypsin Mediated by the Nonhuman Primate Serotype rh.10 Adeno-associated Virus Despite Preexisting Immunity to Common Human Adeno-associated Viruses"],"prefix":"10.1016","volume":"13","author":[{"given":"Bishnu P.","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Heguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.09.003_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(88)90154-4","article-title":"Molecular basis of alpha-1-antitrypsin deficiency","volume":"84","author":"Brantly","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymthe.2005.09.003_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.95.1.196","article-title":"The alpha 1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy","volume":"95","author":"Crystal","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.ymthe.2005.09.003_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114578","article-title":"Alpha 1-antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy","volume":"85","author":"Crystal","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.09.003_bib4","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"4125","article-title":"\u03b11-Antitrypsin deficiency","author":"Cox Wilson","year":"1995"},{"key":"10.1016\/j.ymthe.2005.09.003_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.bi.52.070183.003255","article-title":"Human plasma proteinase inhibitors","volume":"52","author":"Travis","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2005.09.003_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ymthe.2004.08.022","article-title":"Intrapleural administration of a serotype 5 adeno-associated virus coding for \u03b11-antitrypsin mediates persistent, high lung and serum levels of \u03b11-antitrypsin","volume":"10","author":"De","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0042-6822(84)90272-1","article-title":"Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus","volume":"134","author":"Georg-Fries","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2005.09.003_bib8","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","article-title":"Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)","volume":"59","author":"Erles","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib10","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib11","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1128\/JVI.75.13.6199-6203.2001","article-title":"Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer","volume":"75","author":"Hildinger","year":"2001","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymthe.2005.09.003_bib12","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: influence on vector function and effector mechanisms","volume":"11","author":"Bessis","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/hum.1996.7.1-79","article-title":"\u201cSero-switch\u201d adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype","volume":"7","author":"Mastrangeli","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.1997.8.1-99","article-title":"Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype","volume":"8","author":"Mack","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","article-title":"Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes","volume":"74","author":"Halbert","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib16","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.09.003_bib17","first-page":"28","article-title":"Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors","author":"Kok","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2005.09.003_bib18","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","article-title":"Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain","volume":"78","author":"Peden","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib19","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2004-10-3867","article-title":"Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2\/8-mediated, liver-directed gene therapy","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.003_bib20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product","volume":"76","author":"Xiang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1525-0016(16)42832-7","article-title":"Influence of gender-specific hormones on adeno-associated virus vector gene transfer expression","volume":"5","author":"Lonning","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.003_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib24","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib27","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1128\/JVI.74.17.8003-8010.2000","article-title":"CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells","volume":"74","author":"Zhang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1378\/chest.100.3.703","article-title":"Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes","volume":"100","author":"Brantly","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ymthe.2005.09.003_bib29","series-title":"Size, Function and Life History","first-page":"1","year":"1984"},{"key":"10.1016\/j.ymthe.2005.09.003_bib30","doi-asserted-by":"crossref","unstructured":"D. Sondhi, et al. (in press) AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL. Gene Ther. [Electronic publication ahead of print].","DOI":"10.1038\/sj.gt.3302549"},{"key":"10.1016\/j.ymthe.2005.09.003_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.gt.3302039","article-title":"Immune responses to adeno-associated virus and its recombinant vectors","volume":"10","author":"Sun","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib32","first-page":"151","article-title":"Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains","volume":"2","author":"Barr","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib33","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1073\/pnas.95.24.14384","article-title":"Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors","volume":"95","author":"Song","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.09.003_bib34","doi-asserted-by":"crossref","first-page":"124S","DOI":"10.1378\/chest.120.3_suppl.124S","article-title":"Gene therapy in cystic fibrosis","volume":"120","author":"Flotte","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ymthe.2005.09.003_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.2001.tb11361.x","article-title":"AAV-mediated gene transfer for hemophilia","volume":"953","author":"High","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2005.09.003_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14740338.1.1.79","article-title":"Safety of adeno-associated virus gene therapy vectors: a current evaluation","volume":"1","author":"Monahan","year":"2002","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ymthe.2005.09.003_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.physiol.65.092101.142426","article-title":"Current status of gene therapy for inherited lung diseases","volume":"65","author":"Driskell","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1566523034578285","article-title":"From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy","volume":"3","author":"Grimm","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000079988","article-title":"Progress in the use of adeno-associated viral vectors for gene therapy","volume":"177","author":"Buning","year":"2004","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.ymthe.2005.09.003_bib40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ymthe.2004.09.011","article-title":"Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective","volume":"10","author":"Carter","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymthe.2005.09.003_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.gt.3301422","article-title":"Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors","volume":"8","author":"Song","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mthe.2002.0673","article-title":"Intramuscular administration of recombinant adeno-associated virus 2 \u03b1-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects","volume":"6","author":"Song","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/10430340460732490","article-title":"Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults","volume":"15","author":"Flotte","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.09.003_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF02718179","article-title":"Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route","volume":"168","author":"Hubbard","year":"1990","journal-title":"Lung"},{"key":"10.1016\/j.ymthe.2005.09.003_bib46","series-title":"Pleural Diseases","year":"1990"},{"key":"10.1016\/j.ymthe.2005.09.003_bib47","first-page":"39","article-title":"Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum","volume":"232","author":"Perlmutter","year":"2003","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-825639","article-title":"Clinical gene transfer studies for hemophilia B","volume":"30","author":"High","year":"2004","journal-title":"Semin. Thromb. Hemostasis"},{"key":"10.1016\/j.ymthe.2005.09.003_bib49","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1128\/JVI.71.8.5932-5941.1997","article-title":"Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration","volume":"71","author":"Halbert","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib50","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1128\/JVI.72.12.9795-9805.1998","article-title":"Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure","volume":"72","author":"Halbert","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.09.003_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/mthe.2000.0045","article-title":"Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors","volume":"1","author":"Xiao","year":"2000","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605015911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605015911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:03:11Z","timestamp":1586538191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605015911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1525001605015911"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.09.003","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}